Skip to main content
. 2005 Mar 16;23(29):3814–3823. doi: 10.1016/j.vaccine.2005.02.026

Table 2.

Persistent, latent and total level of infection of vaccine groups at the termination of the experiment

Group DNA inoculum
Total no. of animals No. of persistently infected No. of latently infected Persistent + latent infection/total no. of animals
FeLV IL-12 IL-18
A + + + 6 0 2 2/6
B + + 5 3 0 3/5
C + + 6 0 1 1/6
D + 6 4 1 5/6
E + + 6 3 2 5/6
F 6 4 2 6/6